PR Newswire: news distribution, targeting and monitoring

Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets

DUBLIN, Feb 17, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Nanobiotechnology - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Nanobiotechnology in US$ Million.

Companies Profiled:

  • Ablynx NV (Belgium)
  • Arrowhead Pharmaceuticals, Inc. (USA)
  • Avadel Pharmaceuticals plc (Ireland)
  • CaPtivate Pharmaceuticals LLC (USA)
  • Celgene Corporation (USA)
  • ELITechGroup (France)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson (USA)
  • Merck & Co., Inc. (USA)
  • NanoBio® Corporation (USA)
  • Nanophase Technologies Corporation (USA)
  • pSivida Corp. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Starpharma Holdings Ltd. (Australia)
  • Vectura Group plc (UK) Key Topics Covered:
      2. COMPETITIVE SCENARIO

      Developing Countries to Rise over the Horizon

      Nanomaterials & Nanoparticles Witness Robust Activity

      Focus on Improved Performance to Bring New Manufacturing Methods for Nanomaterials

      Why Invest in Nanobiotechnology?

      Private and Public Companies to Step Up Funding on Nanotechnology

      United States Lead the Way in Government Funding

      Increasing Awareness on Technology to Drive Growth

      Demand for Novel Products to Push Up Growth

      Nano-Enabled Drug Discovery Holds Tremendous Potential

      Consolidation Sharpens the Industry's Edge

      4. INDUSTRY CHALLENGES & ISSUES

      5. INDUSTRY STRUCTURE

      6. NANOBIO'S EPOCHAL STRIDES IN MODERN MEDICINE

      7. INNOVATIONS & ADVANCEMENTS

      8. CONCEPTUAL OVERVIEW

      9. GLOBAL RESEARCH CENTERS AND INSTITUTIONS

      10. RECENT INDUSTRY ACTIVITY

      Vectura Group Inks Merger Agreement with Skyepharma Flamel Technologies to Merge with Avadel Pharmaceuticals

      Pfizer to Acquire BIND Therapeutics Assets Janssen Sciences Ireland Enters into Collaboration with ViiV Healthcare

      Tekna Holdings Canada Inks Agreement with National Research Council of Canada Roche and BioMed X Sign a Collaboration Agreement

      Ablynx Enters into Exclusive Research Collaboration with Genzyme

      Pfizer Exercises Option to Develop and Commercialize Accurin BIND Therapeutics Inks Joint Research and Development Agreement with Merck

      11. FOCUS ON SELECT GLOBAL PLAYERS

      12. GLOBAL MARKET PERSPECTIVE

      Total Companies Profiled: 79

      The United States (49)

      Canada (2)

      Japan (1)

      Europe (19)

      - France (2)

      - Germany (6)

      - The United Kingdom (4)

      - Rest of Europe (7)

      Asia-Pacific (Excluding Japan) (5)

      Middle East (3)

      For more information about this report visit http://www.researchandmarkets.com/research/hdjs9m/nanobiotechnology

      Media Contact:

      Research and Markets

      Laura Wood, Senior Manager

      press@researchandmarkets.com

      For E.S.T Office Hours Call +1-917-300-0470

      For U.S./CAN Toll Free Call +1-800-526-8630

      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907

      Fax (outside U.S.): +353-1-481-1716

       

      SOURCE Research and Markets



      RELATED LINKS
      http://www.researchandmarkets.com

 

Hanki sisältöä sivustollesi

Paranna sivustosi tai blogisi sisältöä PR Newswire on räätälöity reaaliaikainen uutispalvelut.
Aloita tänään.

 

 
 

Yhteystiedot PR Newswire

Lähetä meille sähköpostia osoitteeseenfinland@prnewswire.fi or soita +358 46 8 126 226

 

 
 

Ryhdy PR Newswire asiakas

Pyydä lisätietoja noin PR Newswire tuotteista ja palveluista tai soita +358 46 8 126 226

 

 
  1. Tuotteet ja palvelut
  2. Tiedotteet
  3. Ota yhteyttä